Syndax Pharmaceuticals (SNDX) Other Operating Expenses (2019 - 2026)

Syndax Pharmaceuticals' Other Operating Expenses history runs 6 years deep, the most recent figure standing at -$2.5 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 23.57% year-over-year to -$2.5 million; the TTM figure through Mar 2026 stood at -$15.3 million (down 146.92% YoY), while the FY2025 annual figure was $1.3 million, up 419.43% from the prior year.
• Other Operating Expenses was -$2.5 million for Q1 2026 at Syndax Pharmaceuticals, down from -$2.1 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $52.1 million in Q3 2024 to a low of -$11.8 million in Q2 2024.
• Historically, Other Operating Expenses has averaged $2.7 million across 4 years, with a median of -$3.5 million in 2025.
• Biggest YoY gain for Other Operating Expenses was 68.45% in 2025; the steepest drop was 113.44% in 2025.
• A 4-year view of Other Operating Expenses shows it stood at $13.7 million in 2022, then plunged by 132.15% to -$4.4 million in 2024, then surged by 52.6% to -$2.1 million in 2025, then fell by 19.78% to -$2.5 million in 2026.
• The last three Other Operating Expenses figures came in at -$2.5 million (Q1 2026), -$2.1 million (Q4 2025), and -$7.0 million (Q3 2025), per Business Quant data.